Dr. Colin Collins has been awarded a five-year CIHR Project Grant for "Uncovering early mediators of lineage plasticity and validation of a metabolic vulnerability in neuroendocrine prostate cancer" (co-investigators: Dr. YZ Wang and Dr. Martin Gleave).
Dr. Lucia Nappi (MD, PhD) has received a Michael Smith Foundation for Health Research 2020 Health Professional-Investigator Award for her project "Moving towards a biology-based care model in germ cell tumours."
Dr. Lucia Nappi (MD, PhD) has received a 2020 Tad Smith & Caroline Fitzgibbons-PCF Young Investigator Award for her project "Uncovering Lineage Plasticity in the Context of Specific Genomic Alterations in High Risk Prostate Cancer."
Dr. Martin Gleave has been elected to the rank of National Academy of Inventors Fellow. The NAI Fellows Selection Committee inducts as Fellows those who have demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on the quality of life, economic development, and the welfare of society. We congratulate him on this prestigious recognition.
Dr. Artem Cherkasov is co-PI on two CFI Exceptional Opportunity Fund grants awarded November 2020.
Ninadh D’Costa, PhD student in Dr. Alan So's lab, was awarded the Kidney Cancer Research Network of Canada (KCRNC)-SOPER Foundation Grant for her project titled “Identification and validation of a comprehensive gene signature to determine treatment response and guide precision oncology on patients with metastatic clear-cell renal cell carcinoma”.
Dr. Daksh Thaper has been awarded the prestigious Congressionally Directed Medical Research Programs Early Investigator Research Award. He has received funding for his project, "Characterizing and targeting the interplay between transcription factor BRN2 and SWI/SNF chromatin remodeling complex in small cell neuroendocrine prostate cancer." Dr. Thaper is a postdoctoral fellow (PDF) in Dr. Amina Zoubeidi's lab.
Two CIHR Project Grants have been awarded to researchers at our Centre.
Dr YZ Wang and his co-applicants Drs Ci, He and Lin were the recipients of a four-year CIHR Project Grant (Spring 2020 competition) for their proposal, "The role of PRDM16 in neuroendocrine prostate cancer development and aggressiveness."